naltrexone has been researched along with Mood Disorders in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (28.57) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acevedo, LM; Apovian, CM; Dunayevich, E; Greenway, FL; McElroy, SL; Pi-Sunyer, X | 1 |
Howland, RH | 1 |
Spada, MM | 1 |
Cree, BA; Goodin, DS; Kornyeyeva, E | 1 |
Dundon, WD; O'Brien, CP; Pettinati, HM | 1 |
Grinenko, AIa; Krupitskiĭ, EM; Zvartau, EE | 1 |
Koppeschaar, HP; Schagen Van Leeuwen, JH; Te Velde, ER; Van Ree, JM | 1 |
Collins, J; Cramer, J; Gueorguieva, R; Krystal, JH; Rosenheck, R | 1 |
Martin, WR | 1 |
Anderson, B; Koz, G; Volavka, J | 1 |
Kagaya, A; Kugaya, A; Uchitomi, Y; Yamawaki, S; Yokota, N | 1 |
Agman, G; Godart, NT; Jeammet, P; Perdereau, F | 1 |
Peachey, JE | 1 |
Dickerson, PC; Malcolm, R; O'Neil, PM; Von, JM | 1 |
2 review(s) available for naltrexone and Mood Disorders
Article | Year |
---|---|
An overview of problematic internet use.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Central Nervous System Stimulants; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Humans; Internet; Methylphenidate; Mood Disorders; Naltrexone; Narcotic Antagonists; Prevalence; Substance-Related Disorders | 2014 |
Current status of co-occurring mood and substance use disorders: a new therapeutic target.
Topics: Alcoholism; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Controlled Clinical Trials as Topic; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Drug Therapy, Combination; Humans; Mood Disorders; Naltrexone; Narcotic Antagonists; Psychotropic Drugs; Sertraline; Substance-Related Disorders | 2013 |
6 trial(s) available for naltrexone and Mood Disorders
Article | Year |
---|---|
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Topics: Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Pilot Projects; Placebos; Quality of Life; Young Adult | 2010 |
[Pharmacotherapy in heroin addiction: pharmacological approaches to remission stabilization and recurrence prevention].
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Double-Blind Method; Drug Therapy, Combination; Heroin Dependence; Humans; Mood Disorders; Naltrexone; Narcotic Antagonists; Patient Compliance; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2003 |
Unexpected placebo response in premenstrual dysphoric disorder: implication of endogenous opioids.
Topics: beta-Endorphin; Double-Blind Method; Female; Humans; Mood Disorders; Naltrexone; Opioid Peptides; Pilot Projects; Placebo Effect; Premenstrual Syndrome; Surveys and Questionnaires | 2005 |
Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
Topics: Alcohol Drinking; Alcoholism; Antidepressive Agents; Female; Humans; Male; Mood Disorders; Naltrexone; Narcotic Antagonists; Stress Disorders, Post-Traumatic; Treatment Outcome | 2008 |
Naloxone and naltrexone in mental illness and tardive dyskinesia.
Topics: Animals; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Endorphins; Humans; Mood Disorders; Naloxone; Naltrexone; Rats; Schizophrenia | 1982 |
Naltrexone and dysphoria: a double-blind placebo controlled trial.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Naltrexone; Sex Factors | 1987 |
6 other study(ies) available for naltrexone and Mood Disorders
Article | Year |
---|---|
Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis.
Topics: Anti-Obesity Agents; Bupropion; Double-Blind Method; Drug Combinations; Humans; Mood Disorders; Naltrexone; Obesity; Overweight; Prospective Studies; Randomized Controlled Trials as Topic | 2019 |
Therapies for obesity and medication-associated weight gain.
Topics: Animals; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Chronic Disease; Combined Modality Therapy; Diet, Reducing; Disease Models, Animal; Drug Combinations; Exercise; Fructose; Humans; Mood Disorders; Naltrexone; Obesity; Overweight; Phentermine; Psychotic Disorders; Randomized Controlled Trials as Topic | 2013 |
Emerging concepts concerning drug abuse.
Topics: Adolescent; Adult; Animals; Cats; Conditioning, Psychological; Cyclazocine; Dogs; Euphoria; Guinea Pigs; Homeostasis; Humans; Models, Biological; Mood Disorders; Morphine Dependence; Naltrexone; Rats; Receptors, Opioid; Substance-Related Disorders | 1980 |
Effect of interferon-alpha on DOI-induced wet-dog shakes in rats.
Topics: Amphetamines; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Injections, Intraventricular; Interferon alpha-2; Interferon-alpha; Male; Mood Disorders; Motor Activity; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists | 1996 |
Naltrexone treatment of self-injurious behavior.
Topics: Adolescent; Drug Therapy, Combination; Eye Injuries; Humans; Male; Mood Disorders; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Psychotic Disorders; Psychotropic Drugs; Self-Injurious Behavior; Treatment Outcome | 2000 |
The role of drugs in the treatment of opioid addicts.
Topics: Alcoholism; Anxiety; Clonidine; Dextropropoxyphene; Heroin; Humans; Inactivation, Metabolic; Kinetics; Methadone; Mood Disorders; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 1986 |